Peri-interventional control of haemostasis in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma - a rare indication for recombinant factor VIIa

Haemophilia

Volumn 16, Issue 4, 2010, Pages 704-705

  Lechner, D ^a   Eichinger, S ^a   Wanivenhaus, A ^a   Kyrle, P A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADULT; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; BLEEDING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CASE REPORT; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEMOPHILIA A; HEMOSTASIS; HUMAN; HYPERTENSION; LETTER; MALE; NAUSEA; PRIORITY JOURNAL; SKIN ALLERGY; TREATMENT OUTCOME;

ANAPHYLAXIS; ARTHRODESIS; BLOOD TRANSFUSION; BONE CYSTS; FACTOR V DEFICIENCY; FACTOR VIIA; HEMOPHILIA A; HEMORRHAGE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLASMA; RECOMBINANT PROTEINS; SUBTALAR JOINT; TREATMENT OUTCOME;

EID: 77954840260     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02240.x     Document Type: Letter

References (5)

1. Spreafico M, Peyvandi F. Combined factor V and factor VIII deficiency. Semin Thromb Hemost 2009, 35:390-9.
2. Sandler GS, Mallory D, Malamui D, Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev 1995, 9:1-8.
3. Taylor C, Jones H, Davies T. Annual Report. Serious Hazards of Transfusion (SHOT) 2007, http://www.shotuk.org/SHOT_report2007.pdf, Available at. Accessed February 4, 2009
4. Gonzalez-Boullosa R, Ocampo-Martinez R, Alarcon-Martin MJ, Suarez-Rodriguez M, Dominguez-Viguera L, Gonzalez-Fajo G. The use of activated recombinant coagulation factor VII during haemarthroses and synovectomy in a patient with congenital severe factor V deficiency. Haemophilia 2005, 11:167-70.
5. Konkle BA, Ebbesen LS, Erhardtsen E. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. J Thromb Haemost 2007, 5:1904-13.